3 not yet recruiting. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 3 |
| Phase 2 | 3 | Not yet recruiting 3 |
Follow B Cell Malignancies: new trials by email Literature Review of B Cell Malignancies trials Research Report on B Cell Malignancies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD19/70 Bi-specific CAR-T Cell Therapy bi-4SCAR CD19/70 T cells - B Cell Malignancies | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 30 | 2027-06-01 | 2026-08-26 |
| CD19/22 Bi-specific CAR-T Cell Therapy bi-4SCAR CD19/22 T cells - B Cell Malignancies | Phase 1 / Phase 2 | Not yet recruiting | Shenzhen Geno-Immune Medical Institute | 60 | 2027-06-01 | 2026-08-26 |
| A Phase 1/2 Study of T-cell Expressing a Novel CD19 Chimeric-Antigen Receptor (SHB-02-CD19) in Patients With CD19-expressing B-cell Malignancies SHB-02-CD19 (anti CD19 CAR-T cells) - B Cell Malignancies, Acute Lymphobkastic Leukemia | Phase 1 / Phase 2 | Not yet recruiting | Sheba Medical Center | 50 | 2026-06-01 | 2026-03-31 |
Shenzhen Geno-Immune Medical Institute (2) · Sheba Medical Center (1)
China (2) · Israel (1)